Oxidative phosphorylation

From WikiMD's WELLNESSPEDIA

Oxidative phosphorylation (or OXPHOS in short) is the metabolic pathway in which cells use enzymes to oxidize nutrients, thereby releasing energy which is used to produce adenosine triphosphate (ATP). This process takes place in the mitochondria in eukaryotic cells.

Overview[edit]

In eukaryotes, oxidative phosphorylation occurs in the mitochondrion. It is the final metabolic pathway of cellular respiration, after glycolysis and the citric acid cycle (or Krebs cycle), and is the primary method of producing ATP in most aerobic organisms.

Process[edit]

Oxidative phosphorylation involves the reduction of oxygen to water, using reducing equivalents produced in the citric acid cycle, and the generation of ATP. The process consists of an electron transport chain and the process of chemiosmosis.

Electron Transport Chain[edit]

The electron transport chain is a series of protein complexes and small organic molecules embedded in the inner mitochondrial membrane. They accept and donate electrons easily, passing them along the chain from one complex to another.

Chemiosmosis[edit]

Chemiosmosis is the movement of ions across a selectively permeable membrane, down their electrochemical gradient. In the case of oxidative phosphorylation, it is the proton gradient that drives ATP synthesis.

Role in Disease[edit]

Defects in oxidative phosphorylation system are associated with a wide variety of clinical disorders. These include Leigh syndrome, neuropathy, ataxia, and retinitis pigmentosa (NARP).

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.